ONESOURCE

Onesource Specialty Pharma Limited

Pharmaceuticals

Share price

₹1,536

Market cap

₹17,619 Cr

1Y return

▼ 18%

A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.

Investors holding Onesource Specialty Pharma Limited

Motilal Oswal Mutual Fund

Mutual Fund

7.06%

Authum Investment & Infrastructure

AIF

4.96%

Quant Mutual Fund

Mutual Fund

2.17%

SBI Life Insurance

Institution

2.06%

Amansa Holdings

Foreign Investor

1.86%

TI

Think Investments

Foreign Investor

1.79%

Foreign Investor

1.76%

AIF

1.62%

NG

Foreign Investor

1.39%

American Funds (Capital Group)

Foreign Investor

1.36%

Axis Mutual Fund

Mutual Fund

1.33%

TH

Foreign Investor

1.26%

Mirae Asset Mutual Fund

Mutual Fund

1.22%

Investor

1.14%

Recent moves 9

Amansa HoldingsDecreased

Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 3.47% to 1.86%, selling 1,841,289 shares. The value of the remaining shares is ₹334.8 Cr at ₹1571.30 apiece.

FidelityNew position

Fidelity bought 20,20,423 shares of Onesource Specialty Pharma Limited, a 1.76% stake, worth ₹334.02 Cr at ₹1653.20 apiece.

SBI Life InsuranceDecreased

SBI Life Insurance decreased its stake in Onesource Specialty Pharma Limited from 2.53% to 2.06% by selling 535,750 shares. The shares are valued at ₹84.22 crore, calculated at a share price of ₹1571.30.

Axis Mutual FundDecreased

Axis Mutual Fund decreased its stake in Onesource Specialty Pharma Limited from 1.47% to 1.33% by selling 155,669 shares. The value of the shares sold is ₹24.43 crore at ₹1571.30 apiece.

Authum Investment & InfrastructureDecreased

Authum Investment & Infrastructure reduced its stake in Onesource Specialty Pharma Limited from 5.16% to 4.96% by decreasing its shareholding from 5,909,646 to 5,681,844 shares. This involved selling 227,802 shares for ₹35.75 crore at ₹1571.30 apiece, crossing the 5% disclosure threshold.

Timf HoldingsDecreased

Timf Holdings decreased its stake in Onesource Specialty Pharma Limited from 2.20% to 1.26%, selling 1,077,044 shares. The value of the shares sold is ₹169.25 crore at a price of ₹1571.30 per share.

Motilal Oswal Mutual FundIncreased

Motilal Oswal Mutual Fund increased its stake in Onesource Specialty Pharma Limited from 4.99% to 7.06%, buying an additional 23,69,500 shares. This transaction increased their total holdings to 80,94,694 shares, worth ₹1272.06 Cr at ₹1571.30 apiece. This deal crossed the 5% disclosure threshold.

Nova GlobalDecreased

Nova Global sold 10,57,902 shares of Onesource Specialty Pharma Limited for ₹161.86 crore at ₹1,530.00 apiece in a bulk deal.

FidelityNew position

Fidelity bought 20,17,662 shares of Onesource Specialty Pharma Limited for ₹308.70 Cr at ₹1530.00 apiece in a bulk deal.

Track the whales in Onesource Specialty Pharma Limited

Get alerted the moment a top investor buys or sells.